Medically Reviewed by
Dr. Bharat Pothuri, MD, FACG
| Updated 07-13-2026
GastroDoxs provides treatment planning for Crohn’s disease and ulcerative colitis, including flare control, maintenance therapy, nutrition, objective monitoring, and coordination for advanced treatment or surgery.
Inflammatory bowel disease treatment aims to control symptoms, heal inflammation, prevent bowel damage, and maintain durable remission. GastroDoxs GutRescue Mission™ connects disease type, location, severity, prior treatment, complications, infection risk, nutrition, and patient priorities into a personalized treat-to-target plan.
Treatment-stage care connects the diagnosis with practical options, safety review, monitoring, and specialist coordination.
We match treatment to the specific IBD type, affected bowel segments, inflammatory burden, fistulas, strictures, prior medicines, and extraintestinal symptoms.
We review biologics and targeted small molecules according to disease severity, prior exposure, infection risk, pregnancy plans, and patient preference.
We combine symptom review with CRP, fecal calprotectin, imaging, and endoscopy when needed to confirm objective control.
We address anemia, vitamin deficiencies, weight loss, diet concerns, and coordinate colorectal surgery when structural disease or severe colitis requires it.
A clear path from scheduling and records review to a personalized treatment plan.
Share your current inflammatory bowel disease symptoms, diagnosis, treatment history, goals, and the questions you need answered.
Bring colonoscopy and pathology reports, imaging, blood and stool markers, current and prior IBD medicines, vaccine records, infection screening, surgery history, symptom diary, and insurance information.
A GastroDoxs GI specialist reviews the diagnosis, treatment options, safety factors, expected benefits, and whether another specialist or procedure is needed.
Your inflammatory bowel disease plan may include medication, nutrition, lifestyle care, testing, a procedure, monitoring, or coordinated referral.
Your guardians. GastroDoxs GutGuardians™ is an elite team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
Your rescue plan. When your diagnosis is confirmed, GastroDoxs GutRescue Mission™ deploys at full force - a gastroenterologist-led intervention plan delivering advanced colonoscopy, upper endoscopy, capsule endoscopy, and precision biologic and medication management across the full range of digestive conditions and complex GI emergencies - fighting for you with everything we have.
Schedule non-emergency care when you need treatment selection, reassessment, monitoring, or specialist coordination.
Seek evaluation for persistent diarrhea, repeated bleeding, urgency, nighttime bowel movements, recurring pain, anemia, fatigue, fever, or unexplained weight loss.
The care team documents Crohn’s or ulcerative colitis, affected bowel segments, inflammatory burden, narrowing, fistulas, abscesses, nutrition, and extraintestinal disease.
Schedule review when bleeding, diarrhea, pain, urgency, weight loss, fever, perianal symptoms, or abnormal markers continue despite the current plan.
Surgery may be needed for obstruction, perforation, abscess, fistula, dysplasia, cancer risk, severe refractory colitis, or medication failure.
IBD treatment should be individualized by disease type, location, severity, complications, prior therapy, objective inflammatory activity, safety factors, and patient goals.
GastroDoxs provides patient-facing treatment planning for inflammatory bowel disease, including records review, medication and procedure questions, symptom monitoring, insurance guidance, and coordinated referral when another specialist is needed.
The most effective IBD treatment depends on whether the patient has Crohn’s disease or ulcerative colitis, disease location and severity, complications, prior medicines, and personal goals. Options include aminosalicylates, short-term corticosteroids, biologics, targeted small molecules, nutrition support, and surgery.
Crohn’s disease treatment aims to control inflammation, heal the bowel, prevent strictures and fistulas, and maintain remission. Biologics or targeted therapies are commonly used for moderate-to-severe disease, while surgery treats complications but does not cure Crohn’s.
Ulcerative colitis treatment may include rectal or oral mesalamine for selected mild disease, corticosteroids for short-term induction, biologics or targeted small molecules for more active disease, and colectomy for severe, refractory, dysplastic, or complicated disease.
Yes. Many patients achieve remission with medication, nutrition support, and careful monitoring. Surgery is reserved for complications, cancer risk, severe refractory disease, or situations where medical treatment is unsafe or ineffective.
Common classes include aminosalicylates, corticosteroids, immunomodulators, biologic medicines, and targeted small molecules. Selection depends on IBD type, severity, previous treatment, infection risk, pregnancy plans, and insurance.
Biologics block specific inflammatory pathways that drive Crohn’s disease or ulcerative colitis. They can induce and maintain remission, reduce steroid exposure, and help prevent hospitalization and surgery when appropriately selected and monitored.
Diet cannot replace anti-inflammatory treatment for active IBD, but individualized nutrition can reduce symptoms, correct deficiencies, support weight and muscle, and improve tolerance. Unnecessary restrictive diets may worsen nutrition.
Yes. Effective maintenance therapy and treat-to-target monitoring can reduce flares, bowel damage, hospitalization, steroid use, and surgery. Regular follow-up helps identify inflammation before symptoms become severe.
Advanced therapy should be considered for moderate-to-severe disease, high-risk Crohn’s features, steroid dependence, fistulas, significant ulcerative colitis, repeated flares, or inadequate response to conventional treatment.
Warning signs include persistent bleeding, diarrhea, pain, fever, weight loss, anemia, rising CRP or fecal calprotectin, ongoing steroid need, perianal drainage, obstruction symptoms, or new findings on imaging or endoscopy.
Some symptoms improve within days to weeks, but objective healing may take months. The timeline varies by medicine, disease severity, adherence, complications, and whether the treatment reaches the inflamed tissue effectively.
Yes. Many patients achieve clinical and endoscopic remission. IBD is chronic, so maintenance treatment and monitoring usually continue even when symptoms disappear.
Surgery is recommended for obstruction, perforation, abscess, fistula, severe bleeding, dysplasia or cancer, toxic colitis, medication failure, or unacceptable quality-of-life burden. Colectomy can cure colitis in ulcerative colitis, but Crohn’s may recur elsewhere.
A gastroenterologist reviews disease type, location, severity, prior treatment, biomarkers, imaging, endoscopy, complications, infection risk, pregnancy plans, cost, and patient preferences, then sets symptom and objective healing targets.
Helpful changes include not smoking, taking medicines consistently, staying active as tolerated, protecting sleep, managing stress, maintaining vaccinations, eating a nutritionally complete diet, and promptly reporting new symptoms.
Book a GastroDoxs IBD treatment visit for Crohn’s disease or ulcerative colitis flare symptoms, medication decisions, biologic or targeted therapy review, monitoring, nutrition, or surgery coordination.
